Alignment Healthcare, Inc. (ALHC)

Alignment Healthcare's stock (ALHC) has experienced a significant increase of 70.85% between January 2, 2025, and December 31, 2025, with a 74.1% return over the prior year as of January 12, 2026. For the third quarter of 2025, Alignment Healthcare reported revenue of $993.7 million, a 43.5% year-over-year increase, surpassing its previous guidance, and beat analyst estimates for earnings per share, reporting $0.02. As of January 1, 2026, Alignment Healthcare reported a 31% year-over-year membership growth, reaching approximately 275,300 members. General Atlantic disposed of over 11 million shares through an open-market sale valued at approximately $206.5 million on December 12, 2025. Wall Street Zen upgraded the stock from "hold" to "buy" in November 2025, and JPMorgan Chase & Co. increased its target price from $20.00 to $23.00 in December 2025, maintaining an "overweight" rating.

Demand seasonality for Alignment Healthcare's products and services is primarily influenced by the annual enrollment period (AEP) for Medicare Advantage plans, which typically begins in October. The company's actuarial methods for estimating medical expenses consider factors such as seasonality and utilization of healthcare services. The increasing senior population in the U.S. and the growing demand for high-quality senior healthcare services provide a secular tailwind for the managed care industry, including Alignment Healthcare.

Alignment Healthcare, Inc. (ALHC) specializes in providing innovative and personalized healthcare solutions for seniors through its Medicare Advantage plans. The company operates within the managed care and health care plans industry, focusing on a consumer-centric platform to revolutionize the healthcare experience for seniors. Its major products and services include a range of Medicare Advantage plans, offering comprehensive coverage. Alignment Healthcare leverages its proprietary technology, AVA®, and a customized care model to deliver coordinated care, virtual care services, and in-home care programs.

Alignment Healthcare has a growing geographic footprint across several states in the United States. As of early 2022, the company expanded its "senior first" model into 16 new markets, making its plans available in 38 total markets across Arizona, California, Nevada, and North Carolina. The company's operations currently consist of Medicare Advantage Plans in California, North Carolina, Nevada, Arizona, Florida, and Texas, serving 53 counties across these six states under its consumer brand, Alignment Health. Strategic priorities include further geographic expansion by entering new markets and increasing its presence in existing ones, often through partnerships with local healthcare providers and payers.

Alignment Healthcare has maintained a positive brand reputation over the past year. Alignment Health was recognized as one of Newsweek's World's Most Trustworthy Companies for the third consecutive year in September 2025. In August 2025, Alignment Health CEO John Kao was named "Founder of the Year" at the LA Times Studios' OC Executive Forum & Leadership Awards. In July 2025, Alignment Healthcare won a key legal victory, resulting in its Arizona Medicare Advantage plans being elevated to 4 stars. More than 95% of Alignment's members are enrolled in plans rated 4 stars and above by the Centers for Medicare and Medicaid Services (CMS).

Alignment Healthcare, Inc. (ALHC) has a diverse ownership structure, primarily concentrated among institutional investors, who collectively hold a significant majority of the company's shares, ranging from approximately 58.10% to 85.7% of the stock. Major institutional owners include General Atlantic Llc, Vanguard Group Inc, and BlackRock, Inc. Insider ownership accounts for a smaller but notable portion, around 6.6% to 20.07% of the company's stock. John Kao, the founder and CEO, was an early and significant stakeholder.